Not every patient interested in GLP-1 therapy is chasing significant weight loss. Some are focused on metabolic health, inflammation, and long-term healthspan, and want a lower-dose approach built around that goal.
At Denver Wellness & Aesthetics Center (DWAC), GLP-1 microdosing is offered as part of a physician-led longevity strategy, under the direction of Dr. Michael Young, a double board-certified physician in Family and Lifestyle Medicine.
Microdosing uses smaller amounts of the same GLP-1 medications used for weight loss, such as semaglutide, with the goal of supporting metabolic health rather than driving substantial fat loss. The approach is built around your specific biomarkers and health goals, not a scaled-down version of a standard weight loss protocol.
Patients who explore GLP-1 microdosing at DWAC are typically already close to their target weight and are more interested in the metabolic and longevity-related aspects of GLP-1 activity: appetite regulation, blood sugar support, and inflammation management, as part of a broader healthspan strategy.
GLP-1 microdosing is rarely used on its own at DWAC. It’s typically paired with thorough biomarker testing, hormone optimization where appropriate, and other peptide or lifestyle interventions, so the full picture of your metabolic health is being addressed rather than one variable in isolation.
A review of your health history, current biomarkers, and goals to determine whether a microdosing approach fits your situation.
Your starting dose is set specifically for a microdosing goal, not adapted from a standard weight loss titration schedule.
Regular check-ins track your metabolic markers over time, so your provider can adjust your plan based on real data rather than guesswork.
Microdosing uses lower doses aimed at metabolic and longevity support rather than significant weight loss. Learn about standard GLP-1 weight loss therapy if substantial fat loss is your primary goal.
Some patients experience modest weight changes, but significant fat loss is not the primary goal of this approach. Your provider will set expectations based on your specific plan.
Patients who are near their target weight and are more focused on metabolic health, inflammation, and longevity than on additional weight loss are typically the best fit.
Your evaluation considers relevant metabolic and hormonal biomarkers as part of building a program suited to your goals. Specifics are discussed at your consultation.
Yes. It’s commonly paired with hormone optimization, broader peptide therapy, or ongoing biomarker testing as part of a complete longevity strategy.
Because doses are lower, side effects are generally milder than with standard GLP-1 weight loss protocols, though individual response varies. Your care team monitors your progress throughout.
Your provider sets a monitoring schedule based on your program and response, with regular check-ins to track relevant biomarkers over time.
Coverage varies by plan and by medication. Our team can help you understand your options during your consultation.
Every microdosing program begins with a physician evaluation. Call (303) 347-2000 or request a consultation below.
Related: GLP-1 Weight Loss | Retatrutide | Longevity Diagnostics
(303) 347-2000 · 500 E Hampden Ave, Suite 206 · Englewood, CO 80113
